Paris (France), May 31. 2022. Inotrem, an advanced clinical stage biotech company developing TREM- 1 targeting immunotherapies for acute and chronic inflammatory syndromes, announced today
BioEquity Europe, Milan, May 16-18, 2022. Inotrem is pleased to attend BioEquity Europe that will take place in Milan on May 16-18, 2022
LIVES 40, Madrid, May 12-14, 2022. The European Society of Intensive Care Medicine (ESICM) celebrates its 40th anniversary with a three-days event in Madrid.
INOTREM S.A | 54 rue de Ponthieu 75008 PARIS
Inotrem 2022 – Legal notices
INOTREM S.A | 54 rue de Ponthieu 75008 PARIS
Inotrem 2022- Legal notices